ACE2 and Hepatic fibrosis: The initial impetus for the current study was to further investigate the potential therapeutic role of ACE2 and the alternate axis of the RAS in biliary fibrosis, based on previous work showing that both ACE2 up-regulation and infusion of its peptide product Ang-(1-7) inhibited liver fibrosis in a range of animal models21,22.